Return to homepagePandemic Pact

to evaluate and advance a novel technological platform to increase the potency and breadth of monoclonal antibodies against SARS-CoV-2 and other infectious disease agents

Grant number: INV-023398

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $7,323,359

  • Funder

    Gates Foundation

  • Research Location

    Canada

  • Lead Research Institution

    Hospital for Sick Children

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A

2 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions.

Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.